CAT and breast carcinoma: Superoxide dismutase and catalase mimetic-drugs MnTmPyP and 134 have distinct impacts on breast cancer cell proliferation via TNFa-induced NF-B regulations confirm our findings that proposed drugs may have positive effects [29].